Liebmann C, Nawrath S, Ludwig B, Paegelow I
Institute of Biochemistry and Biophysics, Biological Faculty, Friedrich-Schiller-University Jena, Germany.
Eur J Pharmacol. 1993 Apr 28;235(2-3):183-8. doi: 10.1016/0014-2999(93)90135-5.
The type of antagonism exhibited by the potent bradykinin B2 receptor antagonist, Hoe 140, on the rat uterus was investigated using various approaches. In the isolated rat uterus the concentration-response curve of bradykinin was shifted to the right and the maximum effect was reduced after pretreatment with Hoe 140 for 5 min. Shorter times of antagonist pretreatment failed to decrease the maximum effect of bradykinin. In the [3H]BK binding assay Hoe 140 bound with pM affinity to a single site and did not discriminate multiple bradykinin receptors. Studying the bradykinin-induced G protein activation we could verify that Hoe 140 at subnanomolar concentrations selectively antagonized the low-affinity BK receptor in the rat myometrium. At nM concentrations Hoe 140 itself was able to stimulate G proteins. The results suggest that in the rat uterus, differently from guinea pig ileum, Hoe 140 possibly acts as a mixed competitive as well as functional antagonist.
采用多种方法研究了强效缓激肽B2受体拮抗剂Hoe 140对大鼠子宫所表现出的拮抗作用类型。在离体大鼠子宫中,缓激肽的浓度-效应曲线右移,且在用Hoe 140预处理5分钟后最大效应降低。拮抗剂预处理时间较短未能降低缓激肽的最大效应。在[3H]BK结合试验中,Hoe 140以皮摩尔亲和力与单一位点结合,且未区分多种缓激肽受体。研究缓激肽诱导的G蛋白激活时,我们能够证实亚纳摩尔浓度的Hoe 140可选择性拮抗大鼠子宫肌层中的低亲和力BK受体。在纳摩尔浓度时,Hoe 140自身能够刺激G蛋白。结果表明,在大鼠子宫中,与豚鼠回肠不同,Hoe 140可能作为一种混合竞争性及功能性拮抗剂发挥作用。